Moreover, IL-1R2—a decoy receptor for IL-1—has been identified as a susceptibility locus for IBD, further emphasizing the pathogenic relevance of IL-1 signaling as it ceases IL-1-driven processes [104,105,106]. The gene discussed is IL1A; the disease is inflammatory bowel disease.